Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma

Surgery (United States)

Volumn 156, Issue 3, 2014, Pages 651-660

  Li, Tao ^a   Qin, Lun Xiu ^b   Gong, Xiao ^c   Zhou, Jian ^b   Sun, Hui Chuan ^b   Wang, Lu ^b   Qiu, Shuang Jian ^b   Ye, Qing Hai ^b   Fan, Jia ^b  

^a Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^b FUDAN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ESTROGEN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; TIME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907597542     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.04.008     Document Type: Article

References (33)

1. Z. Hassoun, and G.J. Gores Treatment of hepatocellular carcinoma Clin Gastroenterol Hepatol 1 2003 10 18
2. M. Maluccio, and A. Covey Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma CA Cancer J Clin 62 2012 394 399
3. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
4. G. N'Kontchou, J. Paries, and M.T. Htar et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis Clin Gastroenterol Hepatol 4 2006 1062 1068
5. T. Ohki, R. Tateishi, and T. Sato et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients Clin Gastroenterol Hepatol 6 2008 459 464
6. R. Loomba, H.I. Yang, and J. Su et al. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men Clin Gastroenterol Hepatol 8 2010 891 898
7. C.M. Lee, S.N. Lu, and C.S. Changchien et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection Cancer 86 1999 1143 1150
8. T. Li, L.X. Qin, and X. Gong et al. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection Cancer 119 2013 126 135
9. I.O. Ng, M.M. Ng, and E.C. Lai et al. Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach Cancer 75 1995 18 22
10. W.M. Cong, M.C. Wu, and X.H. Zhang et al. Primary hepatocellular carcinoma in women of mainland China. A clinicopathologic analysis of 104 patients Cancer 71 1993 2941 2945
11. L. Benvegnù, G. Fattovich, and F. Noventa et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study Cancer 74 1994 2442 2448
12. E. Villa, G.M. Baldini, and C. Pasquinelli et al. Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol Cancer 62 1988 611 615
13. S.H. Yeh, and P.J. Chen Gender disparity of hepatocellular carcinoma: the roles of sex hormones Oncology 78 Suppl 1 2010 172 179
14. C.M. Lam, J.L. Yong, and A.O. Chan et al. Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related J Clin Gastroenterol 39 2005 533 539
15. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
16. R.T. Poon, S.T. Fan, and I.O. Ng et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 2000 500 507
17. T. Li, J. Fan, and L.X. Qin et al. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver Ann Surg Oncol 18 2011 1955 1963
18. Y. Yang, H. Nagano, and H. Ota et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection Surgery 141 2007 196 202
19. W.E. Naugler, T. Sakurai, and S. Kim et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
20. P. Tandon, and G. Garcia-Tsao Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies Liver Int 29 2009 502 510
21. B. Sangro, M. Herraiz, and M.A. Martinez-Gonzalez et al. Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution Surgery 124 1998 575 583
22. K.K. Christians, H.A. Pitt, and W.S. Rilling et al. Hepatocellular carcinoma: multimodality management Surgery 130 2001 554 559
23. M.W. Yu, H.C. Chang, and S.C. Chang et al. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk Hepatology 38 2003 1393 1400
24. W. Faber, S. Sharafi, and M. Stockmann et al. Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver Surgery 153 2013 510 517
25. E.G. Giannini, S. Marenco, and G. Borgonovo et al. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis Hepatology 56 2012 1371 1379
26. F. Nomura, K. Ohnishi, and Y. Tanabe Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients Cancer 64 1989 1700 1707
27. E.G. Giannini, S. Marenco, and G. Borgonovo et al. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy Cancer 92 2001 126 135
28. M. Ueno, K. Uchiyama, and S. Ozawa et al. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy Ann Surg Oncol 18 2011 3624 3631
29. T.M. Pawlik, K.A. Delman, and J.N. Vauthey et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 2005 1086 1092
30. R. Drozdz, C. Parmentier, and H. Hachad et al. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system Free Radic Biol Med 25 1998 786 792
31. I.S. Fentiman Gamma-glutamyl transferase: risk and prognosis of cancer Br J Cancer 106 2012 1467 1468
32. R.T. Poon Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies Ann Surg Oncol 16 2009 792 794
33. J.R. Bloomer, T.A. Waldmann, and K.R. McIntire et al. Serum alpha-fetoprotein in patients with massive hepatic necrosis Gastroenterology 72 1977 479 492